Literature DB >> 27599250

Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution.

Ganesh Raghu1.   

Abstract

Entities:  

Year:  2016        PMID： 27599250     DOI： 10.1016/S2213-2600(16)30234-X

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  2 in total

1.  Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.

Authors:  Michael Kreuter; Paolo Spagnolo; Wim Wuyts; Elisabetta Renzoni; Dirk Koschel; Francesco Bonella; Toby M Maher; Martin Kolb; Derek Weycker; Klaus-Uwe Kirchgässler; Ulrich Costabel
Journal:  Respiration       Date:  2017-04-12       Impact factor: 3.580

2.  Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials.

Authors:  Ulrich Costabel; Jürgen Behr; Bruno Crestani; Wibke Stansen; Rozsa Schlenker-Herceg; Susanne Stowasser; Ganesh Raghu
Journal:  Respir Res       Date:  2018-09-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.